Corcept Therapeutics (CORT) Reports Q4 EPS of $0.77
Tweet
Share
E-mailGet Alerts CORT Hot Sheet
Price: $117.51 +0.01%
Revenue Growth %: +56.0%
Financial Fact:
Basic and diluted net loss per share: 0.02
Today's EPS Names:
OCCI, ALZN, ASPU, More
Revenue Growth %: +56.0%
Financial Fact:
Basic and diluted net loss per share: 0.02
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Corcept Therapeutics (NASDAQ: CORT) reported Q4 EPS of $0.77, versus $0.04 reported last year. Revenue for the quarter came in at $53.3 million, versus $23.8 million reported last year.
GUIDANCE:
Corcept Therapeutics sees FY2018 revenue of $275-300 million.
For earnings history and earnings-related data on Corcept Therapeutics (CORT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Paychex (PAYX) Tops Q1 EPS by 2c
- Cintas Corp. (CTAS) Tops Q1 EPS by 1c, Offers Guidance
- Aytu BioScience (AYTU) Tops Q4 EPS by 28c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
